This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Regents of the University of Minnesota. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Todd R Lenvik: Innovator in Immunotherapy
Introduction
Todd R Lenvik is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of immunotherapy, particularly in the development of NK engager molecules. His work focuses on enhancing the immune response to treat cancer and other disorders.
Latest Patents
Todd R Lenvik holds a patent for NK engager molecules and methods of use thereof. This invention provides compositions designed to activate NK cells, which are crucial for stimulating an immune response. The patent details a compound that includes an NK engaging domain that binds to CD 16, an NK activating domain linked to the NK engaging domain, and a targeting domain that selectively binds to target cells, specifically targeting CLEC12A.
Career Highlights
Lenvik is affiliated with the University of Minnesota, where he conducts research and develops innovative solutions in the field of immunotherapy. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Todd R Lenvik has collaborated with esteemed colleagues such as Jeffrey S Miller and Martin Felices. These partnerships enhance the research and development of his innovative approaches in immunotherapy.
Conclusion
Todd R Lenvik is a pioneering inventor whose work in NK engager molecules represents a significant advancement in cancer treatment. His contributions to immunotherapy continue to inspire further research and innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile